Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it have clinical significance?

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 562-568

  Wang, Fu Zhang ^a,b,c,d   Linde, Annika ^a,b,c   Hägglund, Hans ^a,b,c   Testa, Marina ^a,b,c   Locasciulli, Anna ^a,b,c   Ljungman, Per ^a,b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c SAN GERARDO HOSPITAL   (Italy)

^d Swedish Institute for Disease Control   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; FOSCARNET; GANCICLOVIR; VALACICLOVIR; VIRUS DNA;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS ISOLATION;

EID: 0033049486     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515142     Document Type: Article

References (36)

1. 1. Furlong TG, Gallucci BB. Pattern of occurrence and clinical presentation of neurological complications in bone marrow transplant patients. Cancer Nurs 1994;17:27-36.
2. 2. Haire WD, Ruby EI, Gordon BG, et al. Multiple organ dysfunction syndrome in bone marrow transplantation. JAMA 1995;274:1289-95.
3. 3. Gallardo D, Ferra C, Berlanga JJ, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18:1135-9.
4. 4. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996;46:1004-9.
5. 5. Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991;184:545-52.
6. 6. Ablashi DV, Lusso P, Hung CL, et al. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer 1988;42:787-91.
7. SF) recovered from the saliva of an HIV-infected individual. Virology 1990;178:113-21.
8. 8. He J, McCarthy M, Zhou Y, Chandran B, Wood C. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996;70: 1296-300.
9. 9. Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993;167:1197-200.
10. 10. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994;170:1586-9.
11. 11. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995;21:571-6.
12. 12. Asano Y, Yoshikawa T, Kajita Y, et al. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992;67: 1484-5.
13. 13. Knox KK, Harrington DP, Carrigan DR. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995;45:288-92.
14. 14. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995;60: 1355-7.
15. 15. Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 1997;52:301-8.
16. 16. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-60.
17. 17. Åkesson-Johansson A, Harmenberg J, Wahren B, Linde A. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother 1990;34:2417-9.
18. 18. Agut H, Aubin JT, Huraux JM. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro [letter]. J Infect Dis 1991;163:1382-3.
19. 19. Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus-6. Antiviral Res 1995;28:343-57.
20. 20. Yoshida M, Yamada M, Chatterjee S, Lakeman F, Nii S, Whitley RJ. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J Virol Methods 1996;58:137-43.
21. 21. Russler SK, Tapper MA, Carrigan DR. Susceptibility of human herpesvirus-6 to acyclovir and ganciclovir [letter]. Lancet 1989;2:382.
22. 22. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975;292:895-902.
23. 23. Wang F-Z, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996;88:3615-20.
24. 24. Yalcin S, Karpuzoglu T, Suleymanlar G, et al. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol 1994;136:183-90.
25. 25. Wolf DG, Spector SA. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992;166:1412-5.
26. 26. Fox JD, Brink NS, Zuckerman MA, et al. Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis 1995;172:1087-90.
27. 27. Jeffery KJM, Read SJ, Peto TEA, Mayon-White RT, Bangham CRM. Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet 1997;349:313-7.
28. 28. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol 1995;47:105-11.
29. 29. Liedtke W, Malessa R, Faustmann PM, Eis-Hubinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-8.
30. 30. Ablashi DV, Bememan ZN, Kramarsky B, Whitman J Jr, Asano Y, Pearson GR. Human herpesvirus-7 (HHV-7): current status. Clinical and Diagnostic Virology 1995;4:1-13.
31. 31. Torigoe S, Coide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K. Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 1996;129:301-5.
32. 32. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996;10:951-8.
33. 33. Bosi A, Zazzi M, Amantini A, et al. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant. Bone Marrow Transplant 1998;22: 285-8.
34. 34. Rieux C, Gautheret-Djean A, Challine-Lehmann D, Kirch C, Agut J, Vernant JP. Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation 1998;65:1408-11.
35. 35. Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998;26:132-7.
36. 36. Lusso P. Human herpesvirus 6 (HHV-6). Antiviral Res 1996;31:1-21.